Takeda Pharmaceutical Co Ltd  

(Public, TYO:4502)   Watch this stock  
Find more results for 4502
5,104.00
-158.00 (-3.00%)
May 2 - Close
TYO data delayed by 20 mins - Disclaimer
Currency in JPY
Range 5,010.00 - 5,113.00
52 week 4,950.00 - 6,609.00
Open 5,010.00
Vol. 2.32M
Mkt cap 4.03T
P/E     -
Div/yield 90.00/3.53
EPS -143.12
Shares 783.48M
Beta     -
Inst. own     -
Jun 24, 2016
Takeda Pharmaceutical Co Ltd Annual Shareholders Meeting (Estimated) - 10:00AM GMT+9 - Add to calendar
May 10, 2016
Full Year 2016 Takeda Pharmaceutical Co Ltd Earnings Presentation (Japanese) - 5:30PM GMT+9 - Add to calendar
May 10, 2016
Full Year 2016 Takeda Pharmaceutical Co Ltd Earnings Press Conference (Japanese) - 4:00PM GMT+9 - Add to calendar
May 10, 2016
Full Year 2016 Takeda Pharmaceutical Co Ltd Earnings Release - 3:00PM GMT+9 - Add to calendar
  

Key stats and ratios

Q4 (Dec '15) 2015
Net profit margin 12.34% -8.05%
Operating margin 11.66% -7.42%
EBITD margin - 7.32%
Return on average assets 5.76% -3.23%
Return on average equity 11.27% -6.33%
Employees 31,328 -
CDP Score - 97 B

Address

4-1-1, Dosho-machi, Chuo-ku
OSAKA-SHI, OSK 540-8645
Japan
+81-6-62042111 (Phone)
+81-6-62042880 (Fax)

Website links

External links

Description

Takeda Pharmaceutical Company Limited is a Japan-based company engaged in the pharmaceutical business. The Ethical Pharmaceutical segment is engaged in the manufacture and sale of pharmaceutical products, such as therapeutic substances for diabetes, circulatory drugs, anticancer drugs, drugs for central neurological diseases, digestive system drugs, hormonal agents, osteoporosis drugs, antibiotic agents, allergy medications, vitamin drops and vaccines, among others. The Healthcare segment manufactures and sells general drugs and medicines, as well as quasi drugs. The Others segment is involved in the manufacture and sale of reagents, clinical diagnostics and chemical products. As of March 31, 2014, the Company had 146 subsidiaries and 17 associated companies.

Officers and directors

Yasuchika Hasegawa Chairman of the Board
Age: 69
Christophe Weber President, Chief Executive Officer, Representative Director
Age: 48
Andrew S. Plump Chief Medical & Scientific Officer, Director
Age: 50
Shinji Honda Senior Managing Director, Corporate Strategy Office, President of Subsidiary
Age: 57
Masato Iwasaki President of Japan Pharma Business Unit, Director
Age: 56
Yorihiko Kojima Independent Director
Age: 74
Masahiro Sakane Independent Director
Age: 74
Fumio Sudo Independent Director
Age: 75